Published in Otolaryngol Head Neck Surg on March 01, 1987
Central vestibular disorders. J Neurol (2007) 0.99
Evaluation of vertiginous children. Eur Arch Otorhinolaryngol (2007) 0.81
New methods for diagnosis and treatment of vestibular diseases. F1000 Med Rep (2010) 0.76
Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis. J Clin Invest (1976) 3.04
Factors influencing endothelial cell proliferation in vitro. J Cell Physiol (1978) 2.99
Thrombogenesis in sickle cell disease. J Lab Clin Med (2001) 2.75
The bleeding time as a screening test for evaluation of platelet function. N Engl J Med (1972) 2.73
Homocystinemia. Vascular injury and arterial thrombosis. N Engl J Med (1974) 2.55
Neutrophil-mediated endothelial injury in vitro mechanisms of cell detachment. J Clin Invest (1981) 2.50
Bleeding complications associated with cardiopulmonary bypass. Blood (1990) 2.43
Platelet and fibrinogen consumption in man. N Engl J Med (1972) 2.20
Lipopolysaccharide-mediated bovine endothelial cell injury in vitro. Lab Invest (1983) 2.08
Ferrokinetics in man. Medicine (Baltimore) (1970) 2.08
Biochemical studies of two patients with the gray platelet syndrome. Selective deficiency of platelet alpha granules. J Clin Invest (1980) 2.01
Studies of platelet and fibrinogen kinetics in patients with prosthetic heart valves. N Engl J Med (1970) 1.99
Thrombokinetics in man. J Clin Invest (1969) 1.99
Osteosarcoma of the head and neck: meta-analysis of nonrandomized studies. Laryngoscope (1997) 1.95
Glutathione redox cycle protects cultured endothelial cells against lysis by extracellularly generated hydrogen peroxide. J Clin Invest (1984) 1.94
The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets. Blood (1980) 1.91
Effective and efficient platelet transfusion strategies that maintain hemostatic protection. Transfusion (1998) 1.86
Exaggerated platelet reactivity in major depression. Am J Psychiatry (1996) 1.72
Neutrophil kinetics in man. J Clin Invest (1976) 1.72
Experimental acute thrombotic stroke in baboons. Stroke (1987) 1.64
Homocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury. Thromb Res (1980) 1.63
Inhibition of thrombus formation by activated recombinant protein C in a primate model of arterial thrombosis. Circulation (1990) 1.52
Interpretation of electrocochleography in Menière's disease and normal subjects. Ann Otol Rhinol Laryngol (1992) 1.48
Antithrombotic effects of combining activated protein C and urokinase in nonhuman primates. Circulation (1991) 1.47
Kinetics of thrombopoiesis. J Clin Invest (1968) 1.43
Activated neutrophils disrupt endothelial monolayer integrity by an oxygen radical-independent mechanism. Lab Invest (1985) 1.40
Circulatory Support 1988. Bleeding and anticoagulation. Ann Thorac Surg (1989) 1.38
Interruption of acute platelet-dependent thrombosis by the synthetic antithrombin D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone. Proc Natl Acad Sci U S A (1988) 1.34
Local intra-arterial fibrinolytic therapy in acute carotid territory stroke. A pilot study. Stroke (1988) 1.34
Thrombin-mediated release of factor VIII antigen from human umbilical vein endothelial cells in culture. Blood (1982) 1.32
Preparation and storage of platelet concentrates. I. Factors influencing the harvest of viable platelets from whole blood. Br J Haematol (1976) 1.32
Mechanisms of thrombocytopenia in varicella. Am J Hematol (1979) 1.30
Magakaryocyte quantitation. J Clin Invest (1968) 1.29
Platelet consumption by arterial prostheses: the effects of endothelialization and pharmacologic inhibition of platelet function. Ann Surg (1977) 1.24
Effect of sulfinpyrazone on homocysteine-induced endothelial injury and arteriosclerosis in baboons. Circ Res (1983) 1.24
Effects of lipopolysaccharide on human endothelial cells in culture. Thromb Res (1983) 1.22
Characteristics of murine megakaryocytic colonies in vitro. Blood (1979) 1.22
Arterial and venous thromboembolism: kinetic characterization and evaluation of therapy. Thromb Diath Haemorrh (1974) 1.22
Thrombin stimulates tissue plasminogen activator release from cultured human endothelial cells. J Clin Invest (1984) 1.21
Interactions of vascular wall cells with collagen gels. Lab Invest (1982) 1.20
Preparation of cryoprecipitated factor VIII concentrates. Transfusion (1977) 1.19
Studies of human plate alpha-granule release in vivo. Blood (1981) 1.19
Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates. J Clin Invest (1993) 1.17
Facial paralysis in the newborn. Otolaryngol Head Neck Surg (1982) 1.17
Central venous stenosis in the hemodialysis patient: incidence and efficacy of endovascular treatment. Cardiovasc Surg (1997) 1.16
Inhibition of platelet-dependent thrombosis by low molecular weight heparin (CY222): comparison with standard heparin. J Lab Clin Med (1989) 1.14
Preparation and storage of platelet concentrates. II. Storage variables influencing platelet viability and function. Br J Haematol (1976) 1.13
Evaluation of storage iron by chelates. Am J Med (1968) 1.13
Flow cytometric analysis of normal human megakaryocytes. Blood (1988) 1.10
Immune-mediated platelet destruction and thrombocytopenia in patients with solid tumours. Br J Haematol (1982) 1.10
Inhibition of platelet-dependent thrombus formation by human activated protein C in a primate model. Blood (1989) 1.08
Thrombolytic therapy in stroke: possibilities and hazards. Stroke (1986) 1.08
Human megakaryocytic progenitors (CFU-M) assayed in methylcellulose: physical characteristics and requirements for growth. J Cell Physiol (1984) 1.07
Neutrophil kinetics in the dog. J Clin Invest (1975) 1.07
Left ventricular thrombi: in vivo detection by indium-111 platelet imaging and two dimensional echocardiography. Am J Cardiol (1981) 1.06
Induction of vascular endothelial growth factor in balloon-injured baboon arteries. A novel role for reactive oxygen species in atherosclerosis. Circ Res (1997) 1.06
Kinetic and functional studies of platelets, fibrinogen, and plasminogen in patients with hepatic cirrhosis. J Lab Clin Med (1982) 1.05
Hemostasis in malignancy. Ann N Y Acad Sci (1974) 1.05
Bleeding after cardiopulmonary bypass. N Engl J Med (1986) 1.04
Effects of monoclonal antibodies against the platelet glycoprotein IIb/IIIa complex on thrombosis and hemostasis in the baboon. J Clin Invest (1988) 1.03
Human endothelial cell migration: stimulation by a released platelet factor. Lab Invest (1978) 1.01
Reduction of pain episodes and prothrombotic activity in sickle cell disease by dietary n-3 fatty acids. Thromb Haemost (2001) 1.00
In vivo evaluation of artificial surfaces with a nonhuman primate model of arterial thrombosis. J Lab Clin Med (1980) 1.00
Lithium enhancement of megakaryocytopoiesis in culture: mediation via accessory marrow cells. Blood (1983) 1.00
Platelet interactions with Dacron vascular grafts. A model of acute thrombosis in baboons. Arteriosclerosis (1985) 0.99
Thrombokinetics in idiopathic thrombocytopenic purpura. Br J Haematol (1970) 0.98
Mechanism of action of dipyridamole. Thromb Res Suppl (1983) 0.97
The beneficial effect of intracarotid urokinase on acute stroke in a baboon model. Stroke (1986) 0.97
The prevalence of migraine in Menière's disease. Laryngoscope (1992) 0.96
Platelet-active drugs: the relationships among dose, effectiveness, and side effects. Chest (1998) 0.96
Ineffective platelet production in thrombocytopenic human immunodeficiency virus-infected patients. Blood (1998) 0.96
Purification of human megakaryocytes by fluorescence-activated cell sorting. Blood (1987) 0.96
Effects of platelet-modifying drugs on arterial thromboembolism in baboons. Aspirin potentiates the antithrombotic actions of dipyridamole and sulfinpyrazone by mechanism(s) independent of platelet cyclooxygenase inhibition. J Clin Invest (1985) 0.95
Physiology of the nose. Otolaryngol Clin North Am (1973) 0.95
Experimental arterial thromboembolism in baboons. Mechanism, quantitation, and pharmacologic prevention. J Clin Invest (1979) 0.94
The role of endothelial cell injury and platelet response in atherogenesis. Thromb Haemost (1978) 0.94
Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty. Am J Cardiol (1987) 0.94
Marrow erythroid and neutrophil cellularity in the dog. J Clin Invest (1975) 0.93
Megakaryocytopoiesis in the mouse: response to varying platelet demand. J Cell Physiol (1981) 0.92
MR imaging of nasal masses. Radiographics (1995) 0.92
Antiplatelet or anticoagulant therapy after coronary artery bypass surgery. A meta-analysis of clinical trials. Ann Intern Med (1989) 0.91
The relation of platelet density to platelet age: survival of low- and high-density 111indium-labeled platelets in baboons. Blood (1986) 0.90
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (third of three parts). N Engl J Med (1975) 0.90
Hirudin interruption of heparin-resistant arterial thrombus formation in baboons. Blood (1991) 0.90
Evaluation of antiplatelet agents in the prevention of aorto-coronary bypass occlusion. Eur Heart J (1986) 0.90
Kinetics of the formed elements of human blood. Blood (1977) 0.90
Binding of the snake venom-derived proteins applaggin and echistatin to the arginine-glycine-aspartic acid recognition site(s) on platelet glycoprotein IIb.IIIa complex inhibits receptor function. J Biol Chem (1990) 0.90
Enhanced thrombolytic and antithrombotic potency of a fibrin-targeted plasminogen activator in baboons. Circulation (1996) 0.90
The kinetics of platelet production and destruction in man. Clin Haematol (1977) 0.89
The endothelium and thrombosis. Annu Rev Med (1980) 0.89
Regulation of platelet-derived growth factor ligand and receptor gene expression by alpha-thrombin in vascular smooth muscle cells. Circ Res (1992) 0.89
On the multiplicity of platelet prostaglandin receptors. II. The use of N-0164 for distinguishing the loci of action for PGI2, PGD2, PGE2 and hydantoin analogs. Prostaglandins (1984) 0.89
Section preparation of human marrow for light microscopy. J Clin Pathol (1976) 0.89
Clinical trials evaluating platelet-modifying drugs in patients with atherosclerotic cardiovascular disease and thrombosis. Circulation (1986) 0.88
Allergic fungal sinusitis. Clin Otolaryngol Allied Sci (1996) 0.88
Prevention of acquired transient defect in platelet plug formation by infused prostacyclin. Blood (1981) 0.88
Activation of platelets in blood perfusing angioplasty-damaged coronary arteries. Flow cytometric detection. Arterioscler Thromb (1992) 0.88
Allergic fungal sinusitis with cranial base erosion. Head Neck (1997) 0.87
Platelet and fibrinogen survival in coronary atherosclerosis. Response to medical and surgical therapy. Am J Cardiol (1977) 0.87